Receptor Interacting Protein Kinases 1/3: The Potential Therapeutic Target for Cardiovascular Inflammatory Diseases

The receptor interacting protein kinases 1/3 (RIPK1/3) have emerged as the key mediators in cell death pathways and inflammatory signaling, whose ubiquitination, phosphorylation, and inhibition could regulate the necroptosis and apoptosis effectually. Recently, more and more studies show great inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Leng, Yiming, Zhang, Ying, Li, Xinyu, Wang, Zeyu, Zhuang, Quan, Lu, Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637748/
https://www.ncbi.nlm.nih.gov/pubmed/34867386
http://dx.doi.org/10.3389/fphar.2021.762334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637748/
https://www.ncbi.nlm.nih.gov/pubmed/34867386
http://dx.doi.org/10.3389/fphar.2021.762334

Ejemplares similares